This is a notification to inform you about House Bill 15-1232 that was passed last year with regard to the emergency use of epinephrine auto-injectors (EPI Pens).
Colorado law now allows businesses to stock and administer epinephrine auto-injectors, including EpiPen, AuviQ, or other types of auto injectors. Under the law, an employee or agent at a business may use an auto-injector on any individual believed to be experiencing anaphylaxis.
In 2015 the Disease Control and Environmental Epidemiology Division (DCEED) of the Colorado Department of Public Health and Environment received guidance in the legislation to provide a training for the use of an epinephrine auto-injector which shall include a certificate of completion. A link to this required training is provided on the webpage mentioned below.
In addition, the use of epinephrine auto-injectors at your business must be reported to DCEED. A link to that reporting site is also included on the webpage mentioned below.
You can find more information about the epinephrine auto-injector here:
https://www.colorado.gov/pacific/cdphe/epinephrine-auto-injector
Lastly, DCEED is required to create an annual report, and to report to the legislature in 2016 if additional guidance is necessary.
For more information you may contact
303-692-2789
erica.bloom@state.co.us
This blog publishes information typically sent to users of the Colorado Health Facilities Interactive (COHFI) system for health care entities regulated by the Colorado Department of Public Health and Environment. Please note that COHFI is the official medium for business communication between the Department and licensed and/or Medicare/Medicaid certified health care entities. Health care entities should continue to monitor their email accounts routinely.
